The addition of immunophenotyping, as done in this case, further helps to differentiate CTCL from pseudo-T-cell lymphomas and cutaneous pseudolymphomas, which often lack the characteristic CD4+ predominance and CD7 loss seen in MF [4,5]. This evidence concerns the gene CD4 and T-cell non-Hodgkin lymphoma.